Asia: Antisera Market 2023

Antisera Market Size in Asia

The Asian antisera market expanded notably to $X in 2022, picking up by X% against the previous year. Over the period under review, consumption saw a resilient increase. The level of consumption peaked in 2022 and is expected to retain growth in the immediate term.

Antisera Production in Asia

In value terms, antisera production totaled $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate prominent growth. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2021 to 2022, production growth failed to regain momentum.

Antisera Exports

Exports in Asia

In 2022, after three years of growth, there was significant decline in shipments abroad of antisera and other blood fractions, when their volume decreased by X% to X tons. In general, exports, however, posted significant growth. The pace of growth appeared the most rapid in 2021 with an increase of X% against the previous year. As a result, the exports attained the peak of X tons, and then contracted remarkably in the following year.

In value terms, antisera exports declined remarkably to $X in 2022. Overall, exports, however, continue to indicate a significant expansion. The growth pace was the most rapid in 2020 when exports increased by X%. The level of export peaked at $X in 2021, and then reduced markedly in the following year.

Exports by Country

China represented the major exporting country with an export of about X tons, which amounted to X% of total exports. It was distantly followed by Singapore (X tons), South Korea (X tons) and Turkey (X tons), together committing a X% share of total exports. India (X tons) followed a long way behind the leaders.

Exports from China increased at an average annual rate of X% from 2012 to 2022. At the same time, South Korea (X%), Turkey (X%), Singapore (X%) and India (X%) displayed positive paces of growth. Moreover, South Korea emerged as the fastest-growing exporter exported in Asia, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of South Korea and Turkey increased by X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, South Korea ($X), Singapore ($X) and China ($X) appeared to be the countries with the highest levels of exports in 2022, together accounting for X% of total exports. Turkey and India lagged somewhat behind, together accounting for a further X%.

Among the main exporting countries, Turkey, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the export price in Asia amounted to $X per ton, jumping by X% against the previous year. Over the period under review, the export price showed a relatively flat trend pattern. Over the period under review, the export prices hit record highs at $X per ton in 2019; however, from 2020 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was South Korea ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Turkey (X%), while the other leaders experienced more modest paces of growth.

Antisera Imports

Imports in Asia

In 2022, after ten years of growth, there was significant decline in overseas purchases of antisera and other blood fractions, when their volume decreased by X% to X tons. Over the period under review, imports, however, continue to indicate a buoyant expansion. The pace of growth was the most pronounced in 2021 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons, and then reduced in the following year.

In value terms, antisera imports totaled $X in 2022. In general, imports, however, showed a resilient expansion. The pace of growth appeared the most rapid in 2019 when imports increased by X% against the previous year. The level of import peaked in 2022 and is expected to retain growth in years to come.

Imports by Country

In 2022, China (X tons), distantly followed by Taiwan (Chinese) (X tons), Singapore (X tons), Japan (X tons), Israel (X tons), the United Arab Emirates (X tons) and Turkey (X tons) were the main importers of antisera and other blood fractions, together mixing up X% of total imports. The Philippines (X tons), South Korea (X tons), Iran (X tons), Malaysia (X tons), India (X tons) and Thailand (X tons) followed a long way behind the leaders.

Imports into China increased at an average annual rate of X% from 2012 to 2022. At the same time, the Philippines (X%), Taiwan (Chinese) (X%), the United Arab Emirates (X%), Singapore (X%), Israel (X%), Malaysia (X%), India (X%), Thailand (X%), Iran (X%), Turkey (X%) and South Korea (X%) displayed positive paces of growth. Moreover, the Philippines emerged as the fastest-growing importer imported in Asia, with a CAGR of X% from 2012-2022. Japan experienced a relatively flat trend pattern. While the share of Taiwan (Chinese) (X p.p.), Singapore (X p.p.), the United Arab Emirates (X p.p.), Israel (X p.p.) and the Philippines (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Turkey (X p.p.), South Korea (X p.p.), China (X p.p.) and Japan (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest antisera importing markets in Asia were Japan ($X), China ($X) and South Korea ($X), with a combined X% share of total imports. Taiwan (Chinese), Turkey, Israel, Singapore, the United Arab Emirates, India, Iran, Thailand, the Philippines and Malaysia lagged somewhat behind, together comprising a further X%.

The Philippines, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia stood at $X per ton in 2022, surging by X% against the previous year. Over the last decade, it increased at an average annual rate of X%. The pace of growth appeared the most rapid in 2018 an increase of X%. The level of import peaked at $X per ton in 2019; however, from 2020 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Japan ($X,598 per ton), while the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Korea (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :